Knoop C et al. |
FK 506 rescue therapy for irreversible airway rejection in heart-lung transplant recipients: report on five cases. |
1994 |
Transplant. Proc. |
pmid:7527957
|
Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Smoter P et al. |
Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. |
2014 |
Transplant. Proc. |
pmid:25380918
|
Yuan QS et al. |
Rescue therapy with tacrolimus in renal graft patients with cyclosporine A-induced hepatotoxicity: a preliminary study. |
2000 |
Transplant. Proc. |
pmid:11119896
|
|
Morphological characteristics of renal allografts showing renal dysfunction under FK 506 therapy: is graft biopsy available to reveal the morphological findings corresponding with FK 506 nephropathy? Japanese FK 506 Study Group. |
1993 |
Transplant. Proc. |
pmid:7679824
|
Kato H et al. |
Spontaneous proliferation of peripheral blood mononuclear cells as an indicator for insufficient plasma levels of FK 506 in the early phase after liver transplantation. |
1994 |
Transplant. Proc. |
pmid:7513481
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Morris RE |
In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use. |
1991 |
Transplant. Proc. |
pmid:1721257
|
Kobayashi M et al. |
FK 506 assay past and present--characteristics of FK 506 ELISA. |
1991 |
Transplant. Proc. |
pmid:1721258
|
Loss M et al. |
Glucose and lipid metabolism in liver transplant patients under long-term tacrolimus (FK 506) monotherapy. |
1996 |
Transplant. Proc. |
pmid:8623210
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Sánchez-Fructuoso AI et al. |
The prevalence of uridine diphosphate-glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T and its influence on mycophenolic acid pharmacokinetics in stable renal transplant patients. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715905
|
Asensio M et al. |
Experience with tacrolimus as primary immunosuppressor in pediatric liver transplant. |
2002 |
Transplant. Proc. |
pmid:11959208
|
Brook NR et al. |
Prograf produces a molecular environment favoring antifibrosis, an effect reversed by the addition of rapamune. |
2005 Jan-Feb |
Transplant. Proc. |
pmid:15808577
|
Millis JM et al. |
Successful use of tacrolimus for initial rejection episodes after liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636569
|
Harihara Y et al. |
Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120116
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Oishi M et al. |
A case of hyperkalemic distal renal tubular acidosis secondary to tacrolimus in living donor liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11120143
|
van Hooff JP et al. |
Tacrolimus and glucose metabolism. |
1999 |
Transplant. Proc. |
pmid:10576044
|
Loréal O et al. |
FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro. |
1991 |
Transplant. Proc. |
pmid:1721289
|
Matsuzaki T et al. |
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. |
1992 |
Transplant. Proc. |
pmid:1373547
|
Soriano S et al. |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation. |
1999 |
Transplant. Proc. |
pmid:10576045
|
Pirenne J et al. |
Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients. |
1996 |
Transplant. Proc. |
pmid:8623472
|
Torio A et al. |
Effect of CYP3A51/3 polymorphism on blood pressure in renal transplant recipients. |
2012 |
Transplant. Proc. |
pmid:23146466
|
Liu M et al. |
C4d-positive acute humoral renal allograft rejection: rescue therapy by immunoadsorption in combination with tacrolimus and mycophenolate mofetil. |
2004 |
Transplant. Proc. |
pmid:15518760
|
Boran M et al. |
Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. |
2014 |
Transplant. Proc. |
pmid:24935296
|
Stratta RJ |
Late acute rejection episodes after vascularized pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9636633
|
Platz KP et al. |
Indications for mycofenolate mofetil therapy after liver transplantation. |
1997 |
Transplant. Proc. |
pmid:9365601
|
Laftavi MR et al. |
African American renal transplant recipients (RTR) require higher tacrolimus doses to achieve target levels compared to white RTR: does clotrimazole help? |
2013 |
Transplant. Proc. |
pmid:24314941
|
Reyes J et al. |
Lymphoproliferative disease after intestinal transplantation under primary FK 506 immunosuppression. |
1994 |
Transplant. Proc. |
pmid:7518137
|
Falkiewicz K et al. |
Tacrolimus decreases tubular phosphate wasting in renal allograft recipients. |
2003 |
Transplant. Proc. |
pmid:14529892
|
Meiser BM et al. |
Simvastatin decreases accelerated graft vessel disease after heart transplantation in an animal model. |
1993 |
Transplant. Proc. |
pmid:7682363
|
O'Rourke M et al. |
Recovery of delayed-type hypersensitivity following liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7533369
|
Fukuzawa M et al. |
Effect of FK 506 on CD4+ and CD8+ T-cell function in vivo. |
1991 |
Transplant. Proc. |
pmid:1721321
|
Reggiani P et al. |
A "steroid-free" tacrolimus and low-dose mycophenolate mofetil primary immunosuppression does not prevent early acute rejection after liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919435
|
Ge J et al. |
Impact of FOXP3 Polymorphisms on the Blood Level of Tacrolimus in Renal Transplant Recipients. |
|
Transplant. Proc. |
pmid:27569929
|
Kapturczak MH et al. |
Pharmacology of calcineurin antagonists. |
2004 |
Transplant. Proc. |
pmid:15041303
|
Yang SS et al. |
A single center, open-label, randomized pilot study to evaluate the safety and efficacy of tacrolimus modified release, Advagraf, versus tacrolimus twice daily, Prograf, in stable renal recipients (single). |
2015 |
Transplant. Proc. |
pmid:25891697
|
Jin KB et al. |
Effects of tacrolimus on antioxidant status and oxidative stress in glioma cells. |
2008 |
Transplant. Proc. |
pmid:18929850
|
Stockmann M et al. |
Influence of immunosuppressive drugs on intestinal epithelial transport function. |
2002 |
Transplant. Proc. |
pmid:12176434
|
Hranjec T et al. |
Benign transient hyperphosphatasemia associated with Epstein-Barr virus enteritis in a pediatric liver transplant patient: a case report. |
2008 |
Transplant. Proc. |
pmid:18589195
|
Malireddy SR et al. |
Altered first-pass effects in a liver transplant recipient explained intraindividual variation in calcineurin inhibitor concentrations: a case report. |
2008 |
Transplant. Proc. |
pmid:18589198
|
Zegarska J et al. |
Tacrolimus Metabolite M-III May Have Nephrotoxic and Myelotoxic Effects and Increase the Incidence of Infections in Kidney Transplant Recipients. |
2016 |
Transplant. Proc. |
pmid:27496443
|
Yuan-Xin L et al. |
Preliminary experience with alemtuzumab induction therapy combined with maintenance low-dose tacrolimus monotherapy in small-bowel transplantation in China. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172275
|
Izutani H et al. |
Graft coronary arteriosclerosis in rat heart transplant model with FK 506 short-term administration. |
1995 |
Transplant. Proc. |
pmid:7533425
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Torre-Cisneros J et al. |
The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. |
1991 |
Transplant. Proc. |
pmid:1721353
|
Colak T et al. |
Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12270321
|
Woodside KJ et al. |
Conversion from cyclosporine to tacrolimus results in improved creatinine but does not alter lipid profile. |
2005 |
Transplant. Proc. |
pmid:15919491
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Sánchez-Pérez B et al. |
Influence of immunosuppression and effect of hepatitis C virus on new onset of diabetes mellitus in liver transplant recipients. |
2008 |
Transplant. Proc. |
pmid:19010171
|
Waller JR et al. |
Primary immunosuppression with tacrolimus is associated with a reduction in renal allograft fibrosis compared with neoral therapy. |
2002 |
Transplant. Proc. |
pmid:12176496
|
Ribes D et al. |
Combined use of tacrolimus and sirolimus in de novo renal transplant patients: current data. |
2005 Jul-Aug |
Transplant. Proc. |
pmid:16182816
|
Sasaki K et al. |
Effect of FK 506 and splenectomy on orthotopic small bowel xenotransplantation in the hamster-to-rat animal models. |
1998 |
Transplant. Proc. |
pmid:9838521
|
Marino IR et al. |
Preoperative assessment of risk in liver transplantation: a multivariate analysis in 2376 cases of the UW era. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123079
|
Alessiani M et al. |
Intestinal transplantation with and without the colon in FK 506 immunosuppressed pigs. |
1996 |
Transplant. Proc. |
pmid:8908021
|
Nozaki S et al. |
Effect of brequinar sodium on accelerated cardiac allograft rejection in presensitized recipients. |
1994 |
Transplant. Proc. |
pmid:7520633
|
Goller AL et al. |
Loss of serum bicarbonate after discordant liver xenotransplantation. |
2000 |
Transplant. Proc. |
pmid:10936383
|
Morris RE et al. |
Immunopharmacology of FK-506. |
1989 |
Transplant. Proc. |
pmid:2468201
|
Tauxe WN et al. |
A comparison of the renal effects (ERPF, GFR, and FF) of FK 506 and cyclosporine in patients with liver transplantation. |
1991 |
Transplant. Proc. |
pmid:1721386
|
Boots JM et al. |
Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. |
2002 |
Transplant. Proc. |
pmid:12176542
|
Citterio F et al. |
Steroid withdrawal from tacrolimus-based therapy in renal transplant patients. |
2002 |
Transplant. Proc. |
pmid:12176545
|
Han DJ et al. |
A 39-month follow-up study to evaluate the safety and efficacy in kidney transplant recipients treated with modified-release tacrolimus (FK506E)-based immunosuppression regimen. |
2012 |
Transplant. Proc. |
pmid:22310592
|
Yang HC et al. |
Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083501
|
Chang HR et al. |
Lack of hepatotoxicity upon sirolimus addition to a calcineurin inhibitor-based regimen in hepatitis virus-positive renal transplant recipients. |
2007 |
Transplant. Proc. |
pmid:17580178
|
Steinmueller T et al. |
The effect of cyclosporine vs FK 506 on glucose metabolism. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083504
|
Galvao FH et al. |
Experimental animal model of graft-versus-host disease (GVHD) after small-bowel transplantation: characteristics of the model and application to developing treatment strategies. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123488
|
Iacona I et al. |
Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123489
|
Tatekawa Y et al. |
Intragraft expression of p38 in rat small bowel transplantation. |
2000 |
Transplant. Proc. |
pmid:10995948
|
Karamperis N et al. |
Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. |
2003 |
Transplant. Proc. |
pmid:12826146
|
Tzakis AG et al. |
FK 506 rescue in chronic graft-versus-host-disease after bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721416
|
Tojimbara T et al. |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. |
1996 |
Transplant. Proc. |
pmid:8658704
|
Dopazo C et al. |
Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient. |
2009 |
Transplant. Proc. |
pmid:19376416
|
Tahir W et al. |
Diffuse Alveolar haemorrhage: a fatal complication after alemtuzumab induction therapy in renal transplantation. |
|
Transplant. Proc. |
pmid:25645795
|
Baran DA et al. |
Can initial tacrolimus trough levels be predicted from clinical variables? |
2004 |
Transplant. Proc. |
pmid:15621157
|
Land W et al. |
Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial. |
2002 |
Transplant. Proc. |
pmid:12176625
|
Zamauskaite A et al. |
FK506 and CsA differ in their effect on intracellular cytokine expression following kidney transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267184
|
El-Safa EA et al. |
Paradoxical response to tacrolimus assessed by interleukin-2 gene expression. |
2006 |
Transplant. Proc. |
pmid:17175263
|
Moura Neto A et al. |
Frequency of Thyroid Dysfunction in Patients With Diabetes Mellitus Before and After Liver Transplantation. |
2018 |
Transplant. Proc. |
pmid:29661439
|
Moura Neto A et al. |
Clinical Profile of Patients With Diabetes Mellitus and Liver Transplantation: Results After a Multidisciplinary Team Intervention. |
2018 |
Transplant. Proc. |
pmid:29661438
|
Donadio C et al. |
Tubular damage and impairment of renal function in transplanted kidneys. |
1998 |
Transplant. Proc. |
pmid:9723381
|
Duzova A et al. |
Triple immunosuppression with or without basiliximab in pediatric renal transplantation: acute rejection rates at one year. |
2003 |
Transplant. Proc. |
pmid:14697926
|
Davies CB et al. |
Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival. |
1991 |
Transplant. Proc. |
pmid:1721448
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Mohsin N et al. |
Low tacrolimus dose requirements in renal transplant recipients in the omani population: implications for pharmacogenetics? |
2005 |
Transplant. Proc. |
pmid:16213259
|
Sigal NH et al. |
Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. |
1991 |
Transplant. Proc. |
pmid:1712132
|
Uber PA et al. |
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267428
|
Lee CM et al. |
Monotherapy with tacrolimus for heart and liver transplant: a case report. |
2014 |
Transplant. Proc. |
pmid:24767396
|
Abe T et al. |
Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. |
2014 |
Transplant. Proc. |
pmid:24767367
|
Isobe M et al. |
Downregulation of endothelin expression in allograft coronary arteries after gene therapy targeting Cdk2 kinase. |
1998 |
Transplant. Proc. |
pmid:9636407
|
Malinowski K et al. |
Effect of different anti-rejection regimens on the expression of differentiation and activation markers on the surface of host lymphocytes. |
2000 |
Transplant. Proc. |
pmid:10856579
|
Matsumoto S et al. |
ET-Kyoto ductal injection and density-adjusted purification combined with potent anti-inflammatory strategy facilitated single-donor islet transplantation: case reports. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692433
|
Bresci S et al. |
Case report: cystic fibrosis, lung transplantation, and the novel H1N1 flu. |
2010 Jul-Aug |
Transplant. Proc. |
pmid:20692461
|
Jørgensen KA et al. |
Optimal time for determination of blood tacrolimus level. |
2001 Nov-Dec |
Transplant. Proc. |
pmid:11750358
|
Loss GE et al. |
Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen. |
1998 |
Transplant. Proc. |
pmid:9636508
|
Kliem V et al. |
Tacrolimus for steroid- and OKT3-resistant rejection in kidney recipients. |
1998 |
Transplant. Proc. |
pmid:9636509
|